Authors:Amanda N Ruggieri, Emory UniversityMark Yarchoan, Johns Hopkins UniversitySubir Goyal, Emory UniversityYuan Liu, Emory UniversityElad Sharon, National Cancer Institute (NCI), BethesdaHelen X Chen, National Cancer Institute (NCI), BethesdaBrian Olson, Emory UniversityChrystal Paulos, Emory UniversityBassel El-Rayes, Emory UniversityShishir Maithel, Emory UniversityNilofer S Azad, Johns Hopkins UniversityGregory Lesinski, Emory University
Authors:Charu Aggarwal, University of PennsylvaniaNabil Saba, Emory UniversityAlain Algazi, University of California San FranciscoAmmar Sukari, Wayne State UniversityTanguy Y Seiwert, Johns Hopkins UniversityMissak Haigentz, Rutgers State UnivMercedes Porosnicu, Wake Forest School of MedicineMarcelo Bonomi, Ohio State UniversityJean Boyer, Inovio PharmaceuticalsMark T Esser, AstraZenecaLily I Cheng, AstraZenecaSonia Agrawal, AstraZenecaEmily C Jennings, AstraZenecaNicholas M Durham, AstraZenecaKarl Fraser, AstraZenecaDelphine Lissa, AstraZenecaMaozhen Gong, AstraZenecaNatalia Ceaicovscaia, AstraZenecaAmaya Gascó Hernández, AstraZenecaRakesh Kumar, AstraZeneca
Authors:Mehmet Bilen, Emory UniversityBrian Rini, Vanderbilt UniversityMartin H Voss, Memorial Sloan Kettering Cancer CenterJames Larkin, Royal Marsden NHS Foundation TrustJohn BAG Haanen, Netherlands Cancer InstituteLaurence Albiges, Inst Gustave RoussyLance C Pagliaro, Mayo ClinicEric G Voog, Clinique Victor HugoElaine T Lam, University of Colorado, AuroraNikolay Kislov, Yaroslavl Regional Clinical Oncological HospitalBradley A McGregor, Dana-Farber Cancer InstituteAly-Khan A Lalani, Juravinski Cancer CenterBo Huang, Pfizer, Groton, ConnecticutAlessandra di Pietro, Pfizer SRLStan Krulewicz, PfizerPaul B Robbins, PfizerToni K Choueiri, Dana-Farber Cancer Institute
Authors:Kenneth C Anderson, Harvard Medical SchoolDaniel Auclair, Multiple Myeloma Research FoundationStacey J Adam, 3Foundation for the National Institutes of HealthAmit Agarwal, Bristol-Myers SquibbMelissa Anderson, Takeda Pharmaceuticals, CambridgeHervé Avet-Loiseau, Institut Universitaire du Cancer de Toulouse-OncopoleMark Bustoros, Cornell UniversityJessica Chapman, Memorial Sloan Kettering Cancer CenterDana E Connors, Foundation for the National Institutes of HealthAjeeta Dash, Takeda Pharmaceuticals, Cambridge, Massachusetts.Alessandra Di Bacco, Takeda Pharmaceuticals, Cambridge, Massachusetts.Ling Du, GlaxoSmithKlineThierry Facon, Lille University HospitalJuan Flores-Montero, University of SalamancaFrancesca Gay, Azienda Ospedaliero Università Città della Salute e della ScienzaIrene M Ghobrial, Harvard Medical SchoolNicole J Gormley, US Center for Drug Evaluation and ResearchIra Gupta, GlaxoSmithKlineHoward Higley, CCS Associates IncJens Hillengass, Roswell Park Cancer InstituteBindu Kanapuru, US Center for Drug Evaluation and ResearchDickran Kazandjian, University of MiamiGary J Kelloff, NCI, NIH, RockvilleIlan R Kirsch, Adapt BiotechnolBrandon Kremer, GlaxoSmithKlineOla Landgren, University of MiamiElizabeth Lightbody, Harvard Medical SchoolOliver C Lomas, Harvard Medical SchoolSagar Lonial, Emory UniversityMaría-Victoria Mateos, University of SalamancaRocio M de Oca, GlaxoSmithKlineLata Mukundan, CCS Associates IncNikhil C Munshi, Harvard Medical SchoolElizabeth K O'Donnell, Massachusetts General HospitalAlberto Orfao, University of SalamancaBruno Paiva, Instituto de Investigacion Sanitaria de Navarra (IDISNA)Reshma Patel, Janssen Research & Development, Spring HouseTrevor J Pugh, University Health NetworkKarthik Ramasamy, Oxford University HospitalsJill Ray, Genentech IncMikhail Roshal, Mem Sloan Kettering Canc CtrJeremy A Ross, AbbVie IncCaroline C Sigman, CCS Associates IncKatie L Thoren, Memorial Sloan Kettering Cancer CenterSuzanne Trudel, University Health Network, Toronto, Ontario, Canada.Gary Ulaner, Hoag Cancer Center, Irvine, California.Nancy Valente, Genentech IncBrendan M Weiss, Janssen Research & DevelopmentElena Zamagni, University of BolognaShaji K Kumar, Mayo Clinic, Rochester
Authors:Kai Sun, Houston Methodist Neal Cancer CenterYitian Xu, Houston Methodist Research InstituteLicheng Zhang, Houston Methodist Research InstitutePolly Niravath, Houston Methodist Neal Cancer CenterJorge Darcourt, Houston Methodist Neal Cancer CenterTejal Patel, Houston Methodist Neal Cancer CenterBin S Teh, Houston Methodist Neal Cancer CenterAndrew M Farach, Houston Methodist Neal Cancer CenterCarlo Guerrero, Houston Methodist Neal Cancer CenterSunil Mathur, Houston Methodist Neal Cancer CenterMark A Sultenfuss, Houston Methodist HospitalNakul Gupta, Houston Methodist HospitalMary R Schwartz, Houston Methodist HospitalSusan L Haley, Houston Methodist HospitalSindhu Nair, Houston Methodist Neal Cancer CenterXiaoxian Li, Emory UniversityThi Truc Anh Nguyen, Emory UniversityJoseph D Butner, Houston Methodist Research InstituteJoe Ensor, Houston Methodist Neal Cancer CenterJaime A Mejia, Merck Res LabsZhuyong Mei, Baylor College of MedicineBrian E Butler, Houston Methodist HospShu-Hsia Chen, Houston Methodist Research InstituteEric H Bernicker, Houston Methodist Neal Cancer CenterJenny C Chang, Houston Methodist Neal Cancer Center
Authors:Daniel A Pollyea, University of ColoradoCourtney D DiNardo, The University of Texas MD Anderson Cancer CenterMartha Arellano, Emory UniversityArnaud Pigneux, CHU BordeauxWalter Fiedler, University Medical Center Hamburg-EppendorfMarina Konopleva, The University of Texas MD Anderson Cancer CenterDavid A Rizzieri, Novant Health Cancer Institute, CharlotteDouglas B Smith, Johns Hopkins MedicineAtsushi Shinagawa, Hitachi General HospitalRoberto M Lemoli, University of GenoaMonique Dail, Genentech IncYinghui Duan, AbbVie IncBrenda Chyla, AbbVie IncJalaja Potluri, AbbVie IncCatherine L Miller, AbbVie IncHagop M Kantarjian, The University of Texas MD Anderson Cancer Center
Authors:Christine H Chung, Moffitt Cancer Center, TampaJiannong Li, Moffitt Cancer Center, TampaConor Steuer, Emory UniversityPriyanka Bhateja, Ohio State UniversityMatthew Johnson, Moffitt Cancer Center, TampaJude Masannat, Moffitt Cancer Center, TampaMaria I Poole, Moffitt Cancer Center, TampaFeifei Song, Moffitt Cancer Center, TampaJuan C Hernandez-Prera, Moffitt Cancer Center, TampaHelen Molina, Moffitt Cancer Center, TampaBruce M Wenig, Moffitt Cancer Center, TampaSunil Kumar, Naveris IncCharlotte Kuperwasser, Naveris IncPhilip J Stephens, Naveris IncJoaquim M Farinhas, Moffitt Cancer Center, TampaDong Shin, Emory UniversityJulie A Kish, Moffitt Cancer Center, TampaJameel Muzaffar, Moffitt Cancer Center, TampaKedar Kirtane, Moffitt Cancer Center, Tampa, FloridaJames W Rocco, Ohio State UniversityMichael J Schell, Moffitt Cancer Center, TampaNabil Saba, Emory UniversityMarcelo Bonomi, Ohio State University
Authors:Funda Meric-Bernstam, The University of Texas MD Anderson Cancer CenterNizar M Tannir, The University of Texas MD Anderson Cancer CenterOthon Iliopoulos, Massachusetts General HospitalRichard J Lee, Massachusetts General HospitalMelinda L Telli, Stanford UniversityAlice C Fan, Stanford UniversityAngela DeMichele, Penn Medicine Abramson Cancer CenterNaomi B Haas, Penn Medicine Abramson Cancer CenterManish R Patel, Florida Canc Specialists Sarah Cannon Res InstJames J Harding, Memorial Sloan Kettering Cancer CenterMartin H Voss, Memorial Sloan Kettering Cancer CenterTaofeek Owonikoko, Emory UniversityBradley Carthon, Emory UniversityRamaprasad Srinivasan, National Cancer Institute, NIH, BethesdaJohanna C Bendell, Sarah Cannon Research Institute/ Tennessee OncologyYonchu Jenkins, Calithera Biosciences, IncSam H Whiting, Calithera Biosciences, IncKeith Orford, Calithera Biosciences, IncMark K Bennett, Calithera Biosciences, IncTodd M Bauer, Sarah Cannon Res Inst Tennessee Oncol
Authors:Clinton Yam, The University of Texas MD Anderson Cancer CenterNour Abuhadra, The University of Texas MD Anderson Cancer CenterRyan Sun, The University of Texas MD Anderson Cancer CenterBeatriz E Adrada, Univ Texas MD Anderson Canc CtrQing-Qing Ding, The University of Texas MD Anderson Cancer CenterJason B White, The University of Texas MD Anderson Cancer CenterElizabeth E Ravenberg, The University of Texas MD Anderson Cancer CenterAlyson R Clayborn, The University of Texas MD Anderson Cancer CenterVicente Valero, The University of Texas MD Anderson Cancer CenterDebu Tripathy, The University of Texas MD Anderson Cancer CenterSenthilkumar Damodaran, The University of Texas MD Anderson Cancer CenterBanu K Arun, The University of Texas MD Anderson Cancer CenterJennifer K Litton, The University of Texas MD Anderson Cancer CenterNaoto T Ueno, The University of Texas MD Anderson Cancer CenterRashmi K Murthy, The University of Texas MD Anderson Cancer CenterBora Lim, Baylor College of MedicineLuis Baez, University of Puerto RicoXiaoxian Li, Emory UniversityAman U Buzdar, The University of Texas MD Anderson Cancer CenterGabriel N Hortobagyi, The University of Texas MD Anderson Cancer CenterAlistair AM Thompson, Baylor College of MedicineElizabeth A. Mittendori, Brigham and Women’s HospitalGaiane M Rauch, The University of Texas MD Anderson Cancer CenterRosalind P Candelaria, The University of Texas MD Anderson Cancer CenterLei Huo, The University of Texas MD Anderson Cancer CenterStacy L Moulder, The University of Texas MD Anderson Cancer CenterJeffrey T Chang, The University of Texas MD Anderson Cancer Center
Authors:R. Harvey, Emory UniversityKathryn F Mileham, Atrium Health, CharlotteVishal Bhatnagar, U.S. Food and Drug Administration, WashingtonJamie R Brewer, U.S. Food and Drug Administration, WashingtonAtiqur Rahman, U.S. Food and Drug Administration, WashingtonCassadie Moravek, Pancreatic Cancer Action NetworkAndrew S Kennedy, Sarah Cannon Research InstituteElizabeth A Ness, National Cancer Institute Center for Cancer Research, BethesdaClaire E Dees, UNC Lineberger Comprehensive Cancer CenterPercy S Ivy, National Cancer Institute Cancer Therapy Evaluation Program, BethesdaScot W Ebbinghaus, Merck & Co., North WalesCaroline Schenkel, American Society of Clinical OncologyThomas S Uldrick, Fred Hutchinson Cancer Research Center, Seattle